Skip to main content
Evidence-Based Supplement Research
Evidence-Based Supplement Research

Lactobacillus acidophilus L-92 and Improved Atopic Dermatitis Symptoms

Research synthesisLow evidenceLarge effect4 studies · 4 beneficial · 0 neutral · 0 harmful

Across 4 studies, all reported beneficial effects of Lactobacillus acidophilus L-92 on atopic dermatitis symptoms, with effect sizes ranging from moderate to large. Two randomized controlled trials in adults and children with clinical atopic dermatitis found statistically significant improvements in SCORAD scores. The evidence base is small, and no consistent dose range or treatment duration could be extracted from the available studies.

  • Studied populations: Adults and children with atopic dermatitis (clinical populations)

Caveats: Evidence base is small (only 4 studies) — conclusions should be considered preliminary. Available evidence is overwhelmingly positive — clinical literature in this area is subject to publication bias (null-result studies are less likely to be published or indexed). Dose and treatment duration were not consistently reported, limiting practical application. Two of the 4 studies are reviews that do not provide independent data.

Generated Jun 11, 2026
Doses used in studies
  • CFU/day: 1 (median 1, IQR 11) 1 study
4 of 4 papers
Back to top